OPKO Health, Inc.
General ticker "OPK" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $1.0B (TTM average)
OPKO Health, Inc. follows the US Stock Market performance with the rate: 4.3%.
Estimated limits based on current volatility of 1.7%: low 1.32$, high 1.37$
Factors to consider:
- Total employees count: 2997 (-23.7%) as of 2024
- US accounted for 76.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses and lack of profitability, Product defects, Dependence on CEO, Regulatory and compliance, Geopolitical risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.11$, 2.30$]
- 2025-12-31 to 2026-12-31 estimated range: [0.97$, 2.08$]
Financial Metrics affecting the OPK estimates:
- Positive: with PPE of -16.8 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -17.46 <= 0.33
- Positive: Inventory ratio change, % of 0.31 <= 0.84
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of -2.36
- Positive: Industry inventory ratio change (median), % of -0.79 <= -0.15
- Positive: 41.86 < Shareholder equity ratio, % of 62.06 <= 63.39
Short-term OPK quotes
Long-term OPK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,004.20MM | $863.50MM | $713.14MM |
| Operating Expenses | $1,230.45MM | $1,020.52MM | $865.21MM |
| Operating Income | $-226.25MM | $-157.02MM | $-152.06MM |
| Non-Operating Income | $-165.65MM | $-27.41MM | $141.70MM |
| Interest Expense | $12.06MM | $13.51MM | $47.47MM |
| R&D Expense | $73.89MM | $89.59MM | $105.21MM |
| Income(Loss) | $-391.90MM | $-184.43MM | $-10.36MM |
| Taxes | $-63.50MM | $4.44MM | $42.84MM |
| Profit(Loss)* | $-328.40MM | $-188.86MM | $-53.22MM |
| Stockholders Equity | $1,561.65MM | $1,389.22MM | $1,365.45MM |
| Inventory | $74.06MM | $65.70MM | $56.80MM |
| Assets | $2,167.26MM | $2,011.70MM | $2,200.21MM |
| Operating Cash Flow | $-95.19MM | $-28.20MM | $-183.49MM |
| Capital expenditure | $24.58MM | $16.27MM | $25.01MM |
| Investing Cash Flow | $91.04MM | $-18.20MM | $352.21MM |
| Financing Cash Flow | $22.97MM | $-11.30MM | $184.17MM |
| Earnings Per Share** | $-0.46 | $-0.25 | $-0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.